1. Home
  2. EPSN vs KZIA Comparison

EPSN vs KZIA Comparison

Compare EPSN & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$5.87

Market Cap

187.2M

Sector

Energy

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$13.88

Market Cap

154.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPSN
KZIA
Founded
2005
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.2M
154.9M
IPO Year
2018
2002

Fundamental Metrics

Financial Performance
Metric
EPSN
KZIA
Price
$5.87
$13.88
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$19.50
AVG Volume (30 Days)
114.8K
197.4K
Earning Date
05-13-2026
06-04-2026
Dividend Yield
4.01%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$295.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$4.86
52 Week High
$6.65
$17.40

Technical Indicators

Market Signals
Indicator
EPSN
KZIA
Relative Strength Index (RSI) 58.60 57.26
Support Level $5.57 $11.32
Resistance Level $5.96 $14.74
Average True Range (ATR) 0.21 1.14
MACD 0.03 0.14
Stochastic Oscillator 77.59 72.01

Price Performance

Historical Comparison
EPSN
KZIA

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: